- Home
- ILMN vs XPEV Comparison
ILMN vs XPEV Comparison
Compare ILMN & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- XPEV
- Stock Information
- Founded
- ILMN 1998
- XPEV 2015
- Country
- ILMN United States
- XPEV China
- Employees
- ILMN N/A
- XPEV N/A
- Industry
- ILMN Medical Specialities
- XPEV Auto Manufacturing
- Sector
- ILMN Health Care
- XPEV Consumer Discretionary
- Exchange
- ILMN Nasdaq
- XPEV Nasdaq
- Market Cap
- ILMN 15.3B
- XPEV 21.7B
- IPO Year
- ILMN 2000
- XPEV 2020
- Fundamental
- Price
- ILMN $120.94
- XPEV $25.84
- Analyst Decision
- ILMN Hold
- XPEV Buy
- Analyst Count
- ILMN 15
- XPEV 8
- Target Price
- ILMN $114.93
- XPEV $22.51
- AVG Volume (30 Days)
- ILMN 1.9M
- XPEV 14.4M
- Earning Date
- ILMN 10-30-2025
- XPEV 11-17-2025
- Dividend Yield
- ILMN N/A
- XPEV N/A
- EPS Growth
- ILMN N/A
- XPEV N/A
- EPS
- ILMN 4.46
- XPEV N/A
- Revenue
- ILMN $4,288,000,000.00
- XPEV $8,416,181,216.00
- Revenue This Year
- ILMN N/A
- XPEV $99.25
- Revenue Next Year
- ILMN $2.22
- XPEV $39.50
- P/E Ratio
- ILMN $26.93
- XPEV N/A
- Revenue Growth
- ILMN N/A
- XPEV 66.37
- 52 Week Low
- ILMN $68.70
- XPEV $11.14
- 52 Week High
- ILMN $153.06
- XPEV $28.24
- Technical
- Relative Strength Index (RSI)
- ILMN 64.55
- XPEV 58.86
- Support Level
- ILMN $118.50
- XPEV $21.60
- Resistance Level
- ILMN $125.50
- XPEV $28.20
- Average True Range (ATR)
- ILMN 5.33
- XPEV 1.27
- MACD
- ILMN 0.79
- XPEV 0.38
- Stochastic Oscillator
- ILMN 85.00
- XPEV 65.96
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.